bpc-157 human clinical evidence review safety trials and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks bpc 157 evidence human clinical

Citations Andrs E et al, "The pathophysiology of elevated vitamin B12 in clinical practice." QJM, June 2013

doi:10.1002/chem.202003788

Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk

2.667 mg 26.67 mg/mL = 0.10 mL, and 0.10 mL 100 = 10 units

NAD+ Intramuscular (IM) Shots help accelerate the healing of muscles, tissues and cells in just 5 minutes

Medication Interactions : Certain medications can interact with vitamin injections